Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Cerami

Showing results (81-90 of 362) with videos related to

Pageof 37
Sort By:
Diabetes|December 1, 1990
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7S Radoff, A Cerami, H Vlassara
Progress in Clinical and Biological Research|January 1, 1991
The role of cachectin/TNF and other cytokines in sepsisA Zentella, K Manogue, A Cerami
Clinical Chemistry|October 1, 1986
Nonenzymatic glycosylation: role in the pathogenesis of diabetic complicationsH Vlassara, M Brownlee, A Cerami
Diabetes|June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetesM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatographyM Brownlee, H Vlassara, A Cerami
Diabetologia|September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptidesH Vlassara, M Brownlee, A Cerami
Diabetes|April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivoH Vlassara, M Brownlee, A Cerami
The Journal of Clinical Investigation|September 1, 1992
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitusM Hogan, A Cerami, R Bucala
Diabetes|September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoproteinM Brownlee, H Vlassara, A Cerami
Diabetes|June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophagesH Vlassara, M Brownlee, A Cerami
Pageof 37

Showing results (81-90 of 362) with videos related to

Sort By:
Pageof 37
Diabetes|December 1, 1990
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7S Radoff, A Cerami, H Vlassara
Progress in Clinical and Biological Research|January 1, 1991
The role of cachectin/TNF and other cytokines in sepsisA Zentella, K Manogue, A Cerami
Clinical Chemistry|October 1, 1986
Nonenzymatic glycosylation: role in the pathogenesis of diabetic complicationsH Vlassara, M Brownlee, A Cerami
Diabetes|June 1, 1984
Inhibition of heparin-catalyzed human antithrombin III activity by nonenzymatic glycosylation. Possible role in fibrin deposition in diabetesM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1980
Measurement of glycosylated amino acids and peptides from urine of diabetic patients using affinity chromatographyM Brownlee, H Vlassara, A Cerami
Diabetologia|September 1, 1982
Assessment of diabetic control by measurement of urinary glycopeptidesH Vlassara, M Brownlee, A Cerami
Diabetes|April 1, 1988
Specific macrophage receptor activity for advanced glycosylation end products inversely correlates with insulin levels in vivoH Vlassara, M Brownlee, A Cerami
The Journal of Clinical Investigation|September 1, 1992
Advanced glycosylation endproducts block the antiproliferative effect of nitric oxide. Role in the vascular and renal complications of diabetes mellitusM Hogan, A Cerami, R Bucala
Diabetes|September 1, 1985
Nonenzymatic glycosylation products on collagen covalently trap low-density lipoproteinM Brownlee, H Vlassara, A Cerami
Diabetes|June 1, 1985
Recognition and uptake of human diabetic peripheral nerve myelin by macrophagesH Vlassara, M Brownlee, A Cerami
Pageof 37